Publicaciones en las que colabora con Guillermo Zalba Goñi (19)

2022

  1. NADPH Oxidase 5 (NOX5) Overexpression Promotes Endothelial Dysfunction via Cell Apoptosis, Migration, and Metabolic Alterations in Human Brain Microvascular Endothelial Cells (hCMEC/D3)

    Antioxidants, Vol. 11, Núm. 11

2021

  1. Inside the Thrombus: Association of Hemostatic Parameters With Outcomes in Large Vessel Stroke Patients

    Frontiers in Neurology, Vol. 12

2020

  1. A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 40, Núm. 5, pp. 1370-1382

  2. NADPH oxidase overactivity underlies telomere shortening in human atherosclerosis

    International Journal of Molecular Sciences, Vol. 21, Núm. 4

2018

  1. Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification

    Atherosclerosis, Vol. 278, pp. 124-134

2017

  1. Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites

    Scientific Reports, Vol. 7

2013

  1. A synthetic peptide from transforming growth factor-β1 Type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats

    Antioxidants and Redox Signaling, Vol. 19, Núm. 14, pp. 1607-1618

  2. Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients

    Journal of Hypertension, Vol. 31, Núm. 3, pp. 587-594

  3. Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis

    Clinical Science, Vol. 125, Núm. 6, pp. 291-300

2012

  1. Blockade of TGF-β 1 signalling inhibits cardiac NADPH oxidase overactivity in hypertensive rats

    Oxidative Medicine and Cellular Longevity

2011

  1. Association of the peroxisome proliferator-activated receptor α gene L162V polymorphism with stage C heart failure

    Journal of Hypertension, Vol. 29, Núm. 5, pp. 876-883

2010

  1. Corrigendum to "Preliminary characterisation of the promoter of the human p22phox gene: Identification of a new polymorphism associated with hypertension" [FEBS Lett. 542 (2003) 27-31]

    FEBS Letters

2007

  1. Phagocytic NADPH oxidase-dependent superoxide production stimulates matrix metalloproteinase-9: Implications for human atherosclerosis

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 27, Núm. 3, pp. 587-593

2003

  1. Preliminary characterisation of the promoter of the human p22phox gene: Identification of a new polymorphism associated with hypertension

    FEBS Letters, Vol. 542, Núm. 1-3, pp. 27-31

  2. The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives

    Journal of Hypertension, Vol. 21, Núm. 11, pp. 2085-2092

2001

  1. Marcadores bioquímicos de fibrosis miocárdica en las enfermedades cardíacas

    Hipertensión y Riesgo Vascular, Vol. 18, Núm. 8, pp. 383-388

  2. Vascular oxidative stress and endothelial dysfunction

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 21 Suppl 1, pp. 61-66

2000

  1. Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of spontaneously hypertensive rats

    Hypertension, Vol. 36, Núm. 6, pp. 1065-1071

1999

  1. Apoptosis of cardiomyocytes in arterial hypertension

    CARDIOVASCULAR RISK FACTORS, Vol. 8, Núm. 5, pp. 257 - 263